vs
BALCHEM CORP（BCPC）与Fiverr International Ltd.（FVRR）财务数据对比。点击上方公司名可切换其他公司
Fiverr International Ltd.的季度营收约是BALCHEM CORP的1.1倍（$287.8M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 1.9%，领先13.0%），过去两年Fiverr International Ltd.的营收复合增速更高（29.5% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Fiverr International Ltd.运营全球在线自由职业服务平台，连接160余个国家的企业客户与独立创作者，提供数字营销、平面设计、编程、文案撰写、视频剪辑等多领域专业服务，满足各类客户灵活的按需用工需求。
BCPC vs FVRR — 直观对比
营收规模更大
FVRR
是对方的1.1倍
$263.6M
净利率更高
BCPC
高出13.0%
1.9%
两年增速更快
FVRR
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $287.8M |
| 净利润 | $39.2M | $5.4M |
| 毛利率 | 35.6% | 82.5% |
| 营业利润率 | 19.8% | -3.5% |
| 净利率 | 14.9% | 1.9% |
| 营收同比 | 9.8% | — |
| 净利润同比 | 16.8% | — |
| 每股收益（稀释后） | $1.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCFVRR
| Q4 25 | $263.6M | — | ||
| Q3 25 | $267.6M | $287.8M | ||
| Q2 25 | $255.5M | $188.2M | ||
| Q1 25 | $250.5M | $93.5M | ||
| Q4 24 | $240.0M | — | ||
| Q3 24 | $239.9M | $269.9M | ||
| Q2 24 | $234.1M | $177.3M | ||
| Q1 24 | $239.7M | $88.0M |
净利润BCPCFVRR
| Q4 25 | $39.2M | — | ||
| Q3 25 | $40.3M | $5.4M | ||
| Q2 25 | $38.3M | $4.1M | ||
| Q1 25 | $37.1M | $788.0K | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $33.8M | $-1.0M | ||
| Q2 24 | $32.1M | $-4.0M | ||
| Q1 24 | $29.0M | $-4.3M |
毛利率BCPCFVRR
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | 82.5% | ||
| Q2 25 | 36.4% | 83.3% | ||
| Q1 25 | 35.2% | 83.5% | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | 82.8% | ||
| Q2 24 | 35.5% | 82.4% | ||
| Q1 24 | 34.0% | 82.2% |
营业利润率BCPCFVRR
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | -3.5% | ||
| Q2 25 | 20.1% | -3.4% | ||
| Q1 25 | 20.4% | -4.4% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | -5.0% | ||
| Q2 24 | 19.6% | -6.3% | ||
| Q1 24 | 17.4% | -8.1% |
净利率BCPCFVRR
| Q4 25 | 14.9% | — | ||
| Q3 25 | 15.1% | 1.9% | ||
| Q2 25 | 15.0% | 2.2% | ||
| Q1 25 | 14.8% | 0.8% | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 14.1% | -0.4% | ||
| Q2 24 | 13.7% | -2.3% | ||
| Q1 24 | 12.1% | -4.9% |
每股收益（稀释后）BCPCFVRR
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $133.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $362.6M |
| 总资产 | $1.7B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCFVRR
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | $133.5M | ||
| Q2 25 | $65.4M | $578.4M | ||
| Q1 25 | $49.9M | $133.5M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | $183.7M | ||
| Q2 24 | $63.7M | $183.7M | ||
| Q1 24 | $60.3M | $183.7M |
股东权益BCPCFVRR
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $362.6M | ||
| Q2 25 | $1.3B | $404.9M | ||
| Q1 25 | $1.2B | $362.6M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $355.8M | ||
| Q2 24 | $1.1B | $355.8M | ||
| Q1 24 | $1.1B | $355.8M |
总资产BCPCFVRR
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $1.0B | ||
| Q1 24 | $1.6B | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $53.0M |
| 自由现金流经营现金流 - 资本支出 | — | $52.1M |
| 自由现金流率自由现金流/营收 | — | 18.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 1.72× | 9.81× |
| 过去12个月自由现金流最近4个季度 | — | $124.9M |
8季度趋势，按日历期对齐
经营现金流BCPCFVRR
| Q4 25 | $67.3M | — | ||
| Q3 25 | $65.6M | $53.0M | ||
| Q2 25 | $47.3M | $42.2M | ||
| Q1 25 | $36.5M | $21.2M | ||
| Q4 24 | $52.3M | — | ||
| Q3 24 | $51.3M | $10.9M | ||
| Q2 24 | $45.0M | $32.2M | ||
| Q1 24 | $33.4M | $21.2M |
自由现金流BCPCFVRR
| Q4 25 | — | — | ||
| Q3 25 | — | $52.1M | ||
| Q2 25 | — | $41.5M | ||
| Q1 25 | — | $20.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | — | $31.5M | ||
| Q1 24 | — | $20.8M |
自由现金流率BCPCFVRR
| Q4 25 | — | — | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 22.0% | ||
| Q1 25 | — | 22.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 17.8% | ||
| Q1 24 | — | 23.7% |
资本支出强度BCPCFVRR
| Q4 25 | — | — | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.4% |
现金转化率BCPCFVRR
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | 9.81× | ||
| Q2 25 | 1.23× | 10.40× | ||
| Q1 25 | 0.98× | 26.90× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
FVRR
暂无分部数据
